Sildenafil Film
Product Images NDC 82347-0205

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 82347-0205). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Yaral Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sildenafil Citrate Is Designated Chemically As 1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1h-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine Citrate, Has The Molecular Formu (Sildenafil Oral Film 01)

Chemical structure of sildenafil citrate, depicting its molecular components and arrangement in a detailed 2D diagram.*

FDA Label Image

Figure 1: Mean Change From Baseline In Supine Systolic Blood Pressure, Healthy Volunteers (Sildenafil Oral Film 02)

A line graph comparing systolic blood pressure (mmHg) over time (hours) in young volunteers aged 18-45. It shows two lines representing Sildenafil 100 mg oral film and placebo, starting from pre-dose and tracking up to 10 hours post-dose. Sildenafil maintains a lower systolic blood pressure compared to placebo after about 4 hours.*

FDA Label Image

Figure 2: Mean Change From Baseline In Supine Systolic Blood Pressure, Elderly (Sildenafil Oral Film 03)

A line graph showing systolic blood pressure (mmHg) over time (hours) for elderly volunteers aged 65 and older. The graph compares two groups: one receiving Sildenafil 100 mg oral film and the other receiving placebo. The systolic blood pressure values fluctuate over a 10-hour period, with the Sildenafil group generally showing lower readings than the placebo group.*

FDA Label Image

Figure 3: Mean Standing Systolic Blood Pressure Change From Baseline (Sildenafil Oral Film 04)

A line graph showing the change in systolic blood pressure (SBP) over time postdose (hours). The graph compares two treatments: Doxazosin with placebo and Doxazosin with Sildenafil 25 mg, with SBP changes plotted from 0 to 8 hours after dosing.*

FDA Label Image

Figure 4: Mean Standing Systolic Blood Pressure Change From Baseline (Sildenafil Oral Film 05)

A line chart depicting the change in systolic blood pressure (mmHg) over time (hours) postdose. Two lines compare the effects of Doxazosin + Placebo versus Doxazosin + Sildenafil 50 mg, showing trends in blood pressure changes over an 8-hour period.*

FDA Label Image

Figure 5: Mean Standing Systolic Blood Pressure Change From Baseline (Sildenafil Oral Film 06)

A line graph showing changes in a variable measured in mmHg over 8 hours after dosing. It compares two groups: Doxazosin combined with Sildenafil 100 mg, and Doxazosin combined with Placebo. The x-axis represents time after dosing in hours, and the y-axis represents the variable's change in mmHg.*

FDA Label Image

Figure 6: Mean Sildenafil Plasma Concentrations In Healthy Male Volunteers (Sildenafil Oral Film 07)

A pharmacokinetic concentration versus time graph showing drug concentration in ng/mL on the y-axis and time in hours on the x-axis. The graph depicts a rapid increase to peak concentration followed by a gradual decline over 24 hours.*

FDA Label Image

Figure 7: Effect Of Sildenafil And Placebo On Maintenance Of Erection By Baseline Score (Sildenafil Oral Film 08)

Two bar graphs comparing the effects of Sildenafil versus Placebo. Each graph shows the number or percentage of patients on the y-axis against baseline scores on the x-axis, with multiple series indicated by different shading or colors for various categories labeled 0 through 5.*

FDA Label Image

Figure 8: Percentage Of Patients Reporting An Improvement In Erections (Sildenafil Oral Film 09)

A bar chart showing the percentage of patients reporting improvement across different treatment groups. The x-axis lists placebo and sildenafil citrate doses (25 mg, 50 mg, 100 mg), with corresponding sample sizes. The y-axis represents percentage improvement, ranging from 0 to 100%, with bars increasing in height from placebo to the highest sildenafil citrate dose.*

FDA Label Image

A (Sildenafil Oral Film 0a)

An instructional illustration showing a hand holding a small rectangular oral film packet. This likely depicts the packaging or handling method for a Sildenafil oral film dosage form, highlighting the ease of use or administration.*

FDA Label Image

B (Sildenafil Oral Film 0b)

An instructional illustration showing a person peeling or opening a film strip or blister pack. The image depicts the hands holding and peeling back a protective layer to access the film dosage form inside.*

FDA Label Image

C (Sildenafil Oral Film 0c)

An instructional illustration showing two hands holding a rectangular film strip, demonstrating how to handle the oral film dosage form of Sildenafil by Yaral Pharma Inc.*

FDA Label Image

D (Sildenafil Oral Film 0d)

Illustration showing a person placing an oral film on their tongue using their fingers. The image demonstrates the correct method for administering a sildenafil citrate oral film.*

FDA Label Image

Principal Display Panelndc 82347-0205-525 mgsildenafil Oral Film25 mg Per Oral Film (Sildenafil Oral Film 0e)

Sildenafil oral film 25 mg packaging label for oral use by Yaral Pharma Inc. The label displays 'Sildenafil oral film 25 mg' prominently, indicating each film contains 25 mg sildenafil citrate. It mentions storage instructions, a net quantity of 4 oral films, and lists inactive ingredients. The label states the film is gluten-free and includes manufacturer and distributor details, with barcodes visible on the sides.*

FDA Label Image

Principal Display Panelndc 82347-0205-625 mgsildenafil Oral Film25 mg Per Oral Film (Sildenafil Oral Film 0f)

Packaging label for Sildenafil oral film 25 mg by Yaral Pharma Inc. The label shows the product name, strength (25 mg per oral film), and quantity (8 oral films). It includes storage instructions and a list of inactive ingredients. The product is marked Rx only, distributed by Yaral Pharma Inc. in New Jersey USA, and made in Poland.*

FDA Label Image

Principal Display Panelndc 82347-0210-550 mgsildenafil Oral Film50 mg Per Oral Film (Sildenafil Oral Film 10)

Sildenafil oral film 50 mg packaging label by Yaral Pharma Inc. The label shows the product name, dosage form as oral film, strength of 50 mg per film, and quantity of 4 films. It includes storage instructions, a bar code, and manufacturing details stating the product is made in Poland. The label also lists inactive ingredients and advises on recommended dosage referencing prescribing information.*

FDA Label Image

Principal Display Panelndc 82347-0215-575 mgsildenafil Oral Film75 mg Per Oral Film (Sildenafil Oral Film 11)

Packaging label for Sildenafil oral film 75 mg by Yaral Pharma Inc. The label states the product name, strength, and form as oral film, with a net quantity of 4 oral films. Storage instructions and inactive ingredients are listed. The product is made in Poland and distributed by Yaral Pharma Inc., Parsippany, NJ.*

FDA Label Image

Principal Display Panelndc 82347-0215-675 mgsildenafil Oral Film75 mg Per Oral Film (Sildenafil Oral Film 12)

Sildenafil oral film 75 mg packaging label showing a box for 8 oral films. The label states the product name and strength, directions to store the light blue oral film in the pouch until use, and manufacturer details for Yaral Pharma Inc. It lists inactive ingredients and notes the product is made in Poland. The label includes barcodes and storage instructions.*

FDA Label Image

Principal Display Panelndc 82347-0220-5100 mgsildenafil Oral Film100 mg Per Oral Film (Sildenafil Oral Film 13)

Sildenafil oral film 100 mg packaging label by Yaral Pharma Inc. The label states the product is an oral film containing 100 mg sildenafil citrate per film, with a net quantity of 4 oral films. It includes storage instructions, a barcode, and distributor information indicating the product is made in Poland and distributed by Yaral Pharma Inc., Parsippany, NJ. The label also lists inactive ingredients and allergy information.*

FDA Label Image

Principal Display Panelndc 82347-0220-6100 mgsildenafil Oral Film100 mg Per Oral Film (Sildenafil Oral Film 14)

The packaging label for Sildenafil oral film contains 100 mg per film and is labeled as Rx only. It includes the active ingredient sildenafil citrate with a net quantity of 8 oral films. The label features storage instructions, distributor Yaral Pharma Inc. from Parsippany, NJ, USA, and indicates the product is made in Poland. Additional inactive ingredients and dosage recommendations refer to prescribing information.*

FDA Label Image

Principal Display Panelndc 82347-0220-4100 mgsildenafil Oral Film100 mg Per Oral Film (Sildenafil Oral Film 15)

Sildenafil oral film 100 mg packaging label displaying the dosage strength prominently in purple. The label indicates the product is an oral film with one film per package. Instructions advise storing the light blue oral film in its pouch until use. The labeler is Yaral Pharma Inc. The NDC is 82347-0220-4 and the product is prescription-only (Rx).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.